IDO1 and neoplasm: The trp-degrading enzyme indoleamine-2,3-dioxygenase (IDO) has been implicated in maternal tolerance towards allogeneic concepti [1], controlling autoimmune diseases [2], [3] and chronic infection [4], as well as promoting tumor immune escape [5], [6], [7].